The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate-Placebo Randomized Controlled Trial
- Resource Type
- Authors
- Shraga Hocherman; Emanuel Tirosh; Yaffa Hadar; Oren Lamm
- Source
- Child psychiatry and human development. 52(1)
- Subject
- Male
medicine.medical_specialty
Audiology
Neuropsychological Tests
Placebo
behavioral disciplines and activities
law.invention
Randomized controlled trial
Double-Blind Method
law
mental disorders
Developmental and Educational Psychology
medicine
Attention deficit hyperactivity disorder
Humans
Attention
Child
Cross-Over Studies
Methylphenidate
Significant difference
medicine.disease
Crossover study
Test (assessment)
Psychiatry and Mental health
Treatment Outcome
Attention Deficit Disorder with Hyperactivity
Pediatrics, Perinatology and Child Health
Central Nervous System Stimulants
Psychology
medicine.drug
- Language
- ISSN
- 1573-3327
To assess the visuomotor attention ability in children with ADHD and controls and their response to placebo and Methylphenidate (MPH) treatment. 36 boys with ADHD and 36 age matched typical controls were administered the visuomotor attention test (VMAT) as a baseline and following a week of MPH(IR) or placebo administered to the study group, in a randomized crossover design. A significant difference between the study and control groups was found on several VMAT measures. No performance difference between ADHD dimensional sub-types was observed at the baseline assessment. Under MPH treatment a significant improvement in VMAT measures was observed and particularly in the combined and predominantly hyperactive (C\HI) type. The VMAT results obtained in the present study are consistent with previous findings. ADHD subtypes appear similarly short of visuomotor attention resources; a visuomotor test can be used in the assessment of gains derived from MPH treatment.